Demant A/S: Completion of capital reduction
Company announcement no 2025-06 | 4 April 2025 |
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2025-04, it was decided at Demant A/S’ ordinary general meeting on 6 March 2025 to reduce the company’s share capital by nominally DKK 1,459,025.80 divided into 7,295,129 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 4 February 2025 less shares to cover share-based retention programmes for senior leadership and the Executive Board.
The capital reduction was published via the electronic information system of the Danish Business Authority on 6 March 2025. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 42,758,932.60.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 42,758,932.60
Number of voting rights: 213.794.663
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Henrik Axel Lynge Buchter, Manager of External Communications |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.